We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia Looking to Reform Orphan Drug Regulations
Australia Looking to Reform Orphan Drug Regulations
The Therapeutic Goods Administration is considering raising the threshold for classifying rare diseases, as well as the number of patients in specific subsets of a disease, to broaden the scope of drugs that qualify for orphan status.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor